NYSE American - Delayed Quote USD
Can-Fite BioPharma Ltd. (CANF)
1.1100
-0.0050
(-0.45%)
At close: May 9 at 4:00:00 PM EDT
1.1086
-0.00
(-0.13%)
After hours: May 9 at 6:07:38 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-7,637
-7,637
-8,440
-10,801
-9,858
Investing Cash Flow
1,495
1,495
498
9,502
-14,511
Financing Cash Flow
6,711
6,711
9,144
0
20,457
End Cash Position
4,825
4,825
4,278
2,978
4,390
Interest Paid Supplemental Data
--
--
0
0
18
Capital Expenditure
-5
-5
-2
-9
-11
Issuance of Capital Stock
6,711
6,711
9,144
0
20,457
Free Cash Flow
-7,642
-7,642
-8,442
-10,810
-9,869
12/31/2021 - 11/6/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ENLV Enlivex Therapeutics Ltd.
1.0200
-2.86%
PPBT Purple Biotech Ltd
2.2050
-0.68%
BLRX BioLineRx Ltd.
3.1700
-0.94%
PLUR Pluri Inc.
5.75
+8.29%
INAB IN8bio, Inc.
0.1574
-6.25%
IRD Opus Genetics, Inc.
0.9468
-4.92%
XTLB XTL Biopharmaceuticals Ltd.
1.2600
+1.61%
XFOR X4 Pharmaceuticals, Inc.
3.3700
+2.43%
CYCC Cyclacel Pharmaceuticals, Inc.
0.2534
-15.53%
CVM CEL-SCI Corporation
0.2468
-3.14%